According to the latest unaudited financial results approved by the Board of Directors on August 1, 2026, India Pesticides reported a significant decline in profitability for the quarter ended June 30, 2026. The company's standalone net profit fell 34.8% to ₹23.07 crore compared to ₹35.38 crore in the corresponding quarter of the previous year, while consolidated PAT declined 34.8% to ₹22.77 crore from ₹34.89 crore in Q1 FY26. The substantial profit decline reflects challenging market conditions and operational pressures, with the company experiencing declines across all key financial metrics during the quarter. Earnings per share (basic and diluted) remained consistent at ₹1.98 for both standalone and consolidated figures, though this represented a 25.6% quarter-on-quarter decline from ₹2.66 in Q4 FY26 and a 34.7% year-on-year decrease from ₹3.03 in Q1 FY26.
The company's standalone revenue from operations declined 8.6% to ₹252.56 crore in Q1 FY27, down from ₹275.41 crore in the same quarter of the previous financial year. On a consolidated basis, total income from operations stood at ₹255.78 crore, declining from ₹270.58 crore in Q4 FY26 and ₹284.10 crore in Q1 FY26. The revenue contraction was primarily attributed to softer domestic demand for the flagship herbicide Pretilachlor and increased operational costs, including job work processing charges which jumped to ₹14 crore from ₹8 crore year-on-year. Despite operational headwinds, export sales showed resilience, increasing marginally to ₹89 crore from ₹87 crore in Q1 FY26, supported by stable international demand across 35+ countries, though this growth was insufficient to offset the domestic slowdown. Total expenses decreased 3.3% quarter-on-quarter to ₹224.93 crore and 5.1% year-on-year to ₹224.93 crore, providing some relief to the bottom line despite the revenue decline.
The company's standalone profit before tax declined 34.1% to ₹31.39 crore from ₹47.62 crore year-on-year, while consolidated profit before tax fell 34% to ₹30.85 crore from ₹47.08 crore in Q1 FY26. Tax expense for the quarter stood at ₹8.08 crores, up from ₹7.25 crores in the previous quarter but down from ₹12.17 crores in Q1 FY26. The divergence between gross profit stability and bottom-line contraction highlights rising operating leverage pressures, as while gross margins have been maintained at healthy levels, downstream manufacturing costs, particularly job work processing charges, eroded profitability. Operating profit margin (OPM) stood at 14.09% in the June 2026 quarter, compared to 16.43% in the corresponding quarter of the previous year, marking a 234 basis point erosion. The quarter-over-quarter decline of 18.5% in profit before tax to ₹30.85 crore from ₹37.86 crore in Q4 FY26 indicates continued operational challenges despite some cost management efforts.
Despite near-term pressures, India Pesticides achieved a key strategic milestone with receipt of Technical Equivalence (TEQ) approval from the European Union for a fungicide product, strengthening its position in international markets and supporting long-term export growth prospects. The company continues to leverage its manufacturing capabilities across two primary facilities in Sandila, Hardoi, and Dewa Road, Lucknow, with a combined permitted capacity of 28,200 MT for technicals and 10,000 MT for formulations. A new facility in Hamirpur is under development, with two out of ten operating blocks currently functional for insecticides and herbicides, and two additional blocks expected to become operational in FY27, contributing to a total permitted capacity expansion of 30,000 MT for technicals and 6,000 MT for formulations. The company is actively reducing dependency on imported intermediates through in-house R&D capabilities, with top 10 customers accounting for 51% of revenue in Q1 FY27, up from 40% in FY26.
The financial results highlight the challenging operating environment facing India Pesticides in the first quarter of FY27. The stock has underperformed significantly, declining 37.24% over the past year compared to the Sensex's 3.81% fall, resulting in a negative alpha of 28.88 percentage points. With a market capitalisation of ₹1,756 crores, the small-cap company faces mounting investor concerns as operational metrics deteriorate across key parameters. The FII holdings collapsed from 1.87% to 0.20% in Q1 FY27, signalling institutional exit, while the company maintains a debt-free balance sheet with net cash position providing financial flexibility during downturns. Management emphasized a focus on operational efficiency and cost management, with Dr. Kuruba Adeppa noting that elevated channel inventory and higher fuel costs further strained profitability in the quarter.
